drugset / Trial / NCT05110599

Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth

NCT05110599 ↗

Phase 2 Terminated 60 enrolled University of Zurich
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The present IIT (Investigator-Initiated Trial) study is a prospective, randomised, placebo-controlled, double blind trial. Women hospitalised with signs of preterm birth can be recruited for the study. Participants will take study medication for 2 weeks (or until birth) and fill out a questionnaire at 3 time points (at baseline, after 1 week and after 2 weeks) to assess state of anxiety and sleep quality. Furthermore, information regarding adverse events and the further course of the pregnancy are recorded.

Timeline

Start
2022-07-12
Primary completion
2023-08-25
Completion
2023-10-01

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment and expired study medication.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bryophyllum pinnatum Traditional medicine (herbal / TCM) 350 mg —

Indications